DaVita Inc. to Participate in the Barclays 2023 Global Healthcare Conference

On March 13, 2023, DaVita Inc. (NYSE: DVA) announced that its Chief Financial Officer, Joel Ackerman, will participate in a fireside chat at the Barclays 2023 Global Healthcare Conference on March 14, 2023, at 3:05 p.m. EDT.

Rhea-AI Summary

On March 13, 2023, DaVita Inc. (NYSE: DVA) announced that its Chief Financial Officer, Joel Ackerman, will participate in a fireside chat at the Barclays 2023 Global Healthcare Conference on March 14, 2023, at 3:05 p.m. EDT. Investors can access the live webcast by visiting the Barclays page and registering for free. DaVita, a leader in kidney care services, serves 200,000 patients across 2,724 outpatient dialysis centers in the U.S. and 350 centers in 11 other countries.

Argus Session date unavailable

+0.51% session move Open Argus

Details

News Market Reaction – DVA

The recorded move for DVA in the trading session of this news was +0.51%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DENVER, March 13, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference on Tuesday, March 14, 2023, at 3:05 p.m. EDT.

To view the live webcast, visit the Barclays page here and create a free registration.  

DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2022, DaVita served 200,000 patients at 2,724 outpatient dialysis centers in the United States. The company also operated 350 outpatient dialysis centers in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Contact Information 
IR@davita.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-to-participate-in-the-barclays-2023-global-healthcare-conference-301770602.html

SOURCE DaVita

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will DaVita participate in the Barclays 2023 Global Healthcare Conference?

DaVita will participate on March 14, 2023, at 3:05 p.m. EDT.

Who is representing DaVita at the Barclays Conference?

Chief Financial Officer Joel Ackerman will represent DaVita.

How can I watch DaVita's presentation at the Barclays Conference?

You can watch the live webcast by registering on the Barclays page.

What is DaVita's stock symbol?

DaVita's stock symbol is DVA.

How many patients does DaVita serve?

As of December 31, 2022, DaVita served 200,000 patients.

Where does DaVita provide its services?

DaVita operates 2,724 outpatient dialysis centers in the U.S. and 350 centers in 11 other countries.